Literature DB >> 23562248

The association between the oxytocin receptor gene (OXTR) and hypnotizability.

Richard A Bryant1, Lynette Hung, Carol Dobson-Stone, Peter R Schofield.   

Abstract

Hypnosis has puzzled scientists for centuries, and particularly the reason why some people are prone to engaging in suggested experiences discordant with external reality. Absorption in internal experience is one key component of the hypnotic response. The neuropeptide oxytocin has been posited to heighten sensitivity to external cues, and it is possible that individual differences in oxytocin-related capacity to engage in external or internal experiences influences hypnotic response. To test this proposal, 185 Caucasian individuals provided saliva samples for analysis of polymorphisms in the oxytocin receptor gene, COMT, and independently completed standardized measures of hypnotizability and absorption. Participants with the GG genotype at rs53576 were characterized by lower hypnotizability and absorption scores than those with the A allele; there was no association between hyponotizability and COMT. These findings provide initial evidence that the capacity to respond to suggestions for altered internal experience is influenced by the oxytocin receptor gene, and is consistent with evidence that oxytocin plays an important role in modulating the extent to which people engage with external versus internal experiences.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Absorption; COMT; Genetic; Hypnotizability; OXTR; Oxytocin

Mesh:

Substances:

Year:  2013        PMID: 23562248     DOI: 10.1016/j.psyneuen.2013.03.002

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  10 in total

1.  KETAMINE AS A POSSIBLE MODERATOR OF HYPNOTIZABILITY: A FEASIBILITY STUDY.

Authors:  David R Patterson; Christine Hoffer; Mark P Jensen; Shelley A Wiechman; Sam R Sharar
Journal:  Int J Clin Exp Hypn       Date:  2018 Jul-Sep

2.  Hypnotizability and Performance on a Prism Adaptation Test.

Authors:  Manuel Menzocchi; Giulio Mecacci; Andrea Zeppi; Giancarlo Carli; Enrica L Santarcangelo
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

3.  Revisiting the association between hypnotisability and blink rate.

Authors:  Francesco Di Gruttola; Paolo Orsini; Maria C Carboncini; Bruno Rossi; Enrica L Santarcangelo
Journal:  Exp Brain Res       Date:  2014-08-20       Impact factor: 1.972

4.  Association of Oxytocin Receptor Gene (OXTR) rs53576 Polymorphism with Sociality: A Meta-Analysis.

Authors:  Jingguang Li; Yajun Zhao; Rena Li; Lucas S Broster; Chenglin Zhou; Suyong Yang
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

5.  Epigenetic Modification of OXTR is Associated with Openness to Experience.

Authors:  Brian W Haas; Alicia K Smith; Shota Nishitani
Journal:  Personal Neurosci       Date:  2018-07-18

6.  Linear and non linear measures of pupil size as a function of hypnotizability.

Authors:  Antonio Lanatà; Alberto Greco; Mirco Ciardelli; Allison Uvelli; Elisabetta Fratini; Diego Manzoni; Enzo P Scilingo; Enrica L Santarcangelo; Laura Sebastiani
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

7.  Individual Traits and Pain Treatment: The Case of Hypnotizability.

Authors:  Enrica Laura Santarcangelo; Giancarlo Carli
Journal:  Front Neurosci       Date:  2021-06-02       Impact factor: 4.677

Review 8.  Review of eating disorders and oxytocin receptor polymorphisms.

Authors:  Victoria Burmester; Dasha Nicholls; Alexis Buckle; Boban Stanojevic; Marta Crous-Bou
Journal:  J Eat Disord       Date:  2021-07-13

9.  The Prefrontal Cortex and Suggestion: Hypnosis vs. Placebo Effects.

Authors:  Benjamin A Parris
Journal:  Front Psychol       Date:  2016-03-30

10.  Genetic modulation of oxytocin sensitivity: a pharmacogenetic approach.

Authors:  F S Chen; R Kumsta; F Dvorak; G Domes; O S Yim; R P Ebstein; M Heinrichs
Journal:  Transl Psychiatry       Date:  2015-10-27       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.